Page last updated: 2024-12-05

acetylenedicarboxylic acid dimethyl ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Acetylenedicarboxylic acid dimethyl ester is a colorless liquid that is synthesized by reacting acetylene with methanol in the presence of a catalyst. It is a versatile building block in organic synthesis and is used in the preparation of various other organic compounds. It is also an important precursor to polymers, pharmaceuticals, and other industrial chemicals. The compound is known for its high reactivity and has been investigated for its potential applications in materials science, as a photoinitiator in polymerizations, and for its use in the synthesis of various heterocyclic compounds. Its unique structure and reactivity make it an intriguing molecule for research and development.'

acetylenedicarboxylic acid dimethyl ester: inhibitor of oxidative phosphorylation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12980
CHEMBL ID3248452
SCHEMBL ID25706
MeSH IDM0079596

Synonyms (76)

Synonym
unii-7hza2pl15f
4-02-00-02291 (beilstein handbook reference)
7hza2pl15f ,
2-butynedioic acid, 1,4-dimethyl ester
AKOS009028881
1,4-dimethyl but-2-ynedioate
EN300-19219
but-2-ynedioic acid dimethyl ester
1,2-bis(methoxycarbonyl)ethyne
dimethyl ethynedicarboxylate
einecs 212-098-4
nsc 14912
dimethyl acetylenedicarboxylic acid
brn 0607063
di(carbomethoxy)acetylene
nsc-14912
1,2-bis(methoxycarbonyl)acetylene
nsc14912
bis(methoxycarbonyl)acetylene
dimethyl 2-butynedioate
methyl acetylenedicarboxylate
762-42-5
acetylenedicarboxylic acid, dimethyl ester
acetylenedicarboxylic acid dimethyl ester
dimethyl acetylenedicarboxylate
2-butynedioic acid, dimethyl ester
dimethyl butynedioate
wln: 1ov1uu1vo1
nsc-101119
nsc101119
inchi=1/c6h6o4/c1-9-5(7)3-4-6(8)10-2/h1-2h
dimethyl but-2-ynedioate
dimethyl acetylenedicarboxylate, 99%
NCGC00165984-01
A0090
dmad
dimethyl but-2-ynedioate;dimethyl acetylenedicarboxylate
A838653
FT-0625034
dimethyl but-2-yne-1,4-dioate
CHEMBL3248452
SCHEMBL25706
bis(carbomethoxy)acetylene
dimethyl butyne-1,4-dioate
butynedioic acid dimethyl ester
dimethyl 1,2-acetylenedicarboxylate
DTXSID0061088
dimethylacetylene dicarboxylate
acetylene dicarboxylic acid, dimethyl ester
dimethylacetylendicarboxylate
acetylene-dicarboxylic acid dimethyl ester
dimethyl-acetylene dicarboxylate
dimethyl ethyne dicarboxylate
dimethylacetylenedicarboxylate
2-butynedioic acid dimethyl ester
dimethylacetylene-dicarboxylate
dimethyl acetylendicarboxylate
dimethyl-acetylenedicarboxylate
acetylene dicarboxylic acid dimethyl ester
dimethyl acetylene-dicarboxylate
dicarbomethoxyacetylene
dimethyl acetylene dicarboxylate
AM87182
W-104370
STR01625
mfcd00008456
F0001-1934
CS-D0471
Q904788
STL185544
BBL036264
dimethyl-2-butynedioate
dimethyl acetylenedicarboxy-late
F30113
dimethylbut-2-ynedioate
Z104473200

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Previously, we determined that diethyl acetylenedicarboxylate (DAD), a protein cross-linker, was significantly more toxic than analogous monofunctional electrophiles."( Enhanced toxicity of the protein cross-linkers divinyl sulfone and diethyl acetylenedicarboxylate in comparison to related monofunctional electrophiles.
Brown, HA; Justice, SL; Morano, KA; Stamm, CE; West, JD, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (25)

Assay IDTitleYearJournalArticle
AID1432759Inhibition of Sporosarcina pasteurii CCM 2056 urease assessed as reduction in ammonia production by measuring initial state enzyme-inhibitor complex using urea as substrate measured for 120 mins by phenol-hypochlorite method2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1136546Antifungal activity against Aspergillus niger ATCC 1004 at <100 ug/ml at pH 7 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136570Antifungal activity against Candida albicans ATCC 10231 at <100 ug/ml at pH 7 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1432763Glutathione reactivity in pH 7.4 PBS measured after 6 to 36 hrs in presence of 1.375 mmol GSH by DTNB reagent based spectrophotometric method2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1136568Antifungal activity against Candida albicans ATCC 10231 at <100 ug/ml at pH 7 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136566Antifungal activity against Candida albicans ATCC 10231 at <100 ug/ml at pH 5.6 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1432756Reversible inhibition of Sporosarcina pasteurii CCM 2056 urease assessed as reduction in ammonia production by measuring recovery of enzyme activity at 10 times IC50 preincubated for 60 mins followed by 100-fold dilution in to PBS containing urea as subst2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1432760Inhibition of Sporosarcina pasteurii CCM 2056 urease assessed as reduction in ammonia production by measuring steady state enzyme-inhibitor complex using urea as substrate measured for 120 mins by phenol-hypochlorite method2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1136547Antifungal activity against Mucor mucedo ATCC 7941 at pH 5.6 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136558Antifungal activity against Trichophyton mentagrophytes ATCC 9129 at <100 ug/ml at pH 5.6 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136554Antifungal activity against Mucor mucedo ATCC 7941 at <100 ug/ml at pH 7 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136544Antifungal activity against Aspergillus niger ATCC 1004 at <100 ug/ml at pH 7 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1432755Competitive inhibition of Sporosarcina pasteurii CCM 2056 urease assessed as reduction in ammonia production preincubated with enzyme followed by addition of varying levels of urea as substrate measured for 120 mins by Lineweaver-Burk plot analysis2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1136542Antifungal activity against Aspergillus niger ATCC 1004 at <100 ug/ml at pH 5.6 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1432751Inhibition of Sporosarcina pasteurii CCM 2056 urease assessed as reduction in ammonia production using urea as substrate measured for 120 mins by phenol-hypochlorite method2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1136549Antifungal activity against Mucor mucedo ATCC 7941 at pH 5.6 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136551Antifungal activity against Mucor mucedo ATCC 7941 at pH 7 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136555Antifungal activity against Trichophyton mentagrophytes ATCC 9129 at pH 5.6 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1432752Cytotoxicity against mouse BALB/3T3 cells assessed as reduction in cell proliferation after 72 hrs by SRB assay2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1136562Antifungal activity against Trichophyton mentagrophytes ATCC 9129 at <100 ug/ml at pH 7 after 5 days in presence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1432761Glutathione reactivity up to 15 mins in presence of 10 mM GSH by 1H NMR analysis2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1136564Antifungal activity against Candida albicans ATCC 10231 at <100 ug/ml at pH 5.6 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1136572Antifungal activity against Aspergillus niger ATCC 1004 at <100 ug/ml at pH 5.6 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
AID1432754Time-dependent Sporosarcina pasteurii CCM 2056 urease assessed as reduction in ammonia production using urea as substrate by phenol-hypochlorite method2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
AID1136560Antifungal activity against Trichophyton mentagrophytes ATCC 9129 at <100 ug/ml at pH 7 after 5 days in absence of 10% beef serum1977Journal of medicinal chemistry, Apr, Volume: 20, Issue:4
Antifungal properties of 2-bromo-3-fluorosuccinic acid esters and related compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (7.89)18.7374
1990's1 (2.63)18.2507
2000's15 (39.47)29.6817
2010's15 (39.47)24.3611
2020's4 (10.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.63 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index5.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.50%)4.05%
Observational0 (0.00%)0.25%
Other39 (97.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]